BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AGuIX readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of AGuIX\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT04881032-2333@assetmemo.bio
DTSTAMP:20261121T005618Z
DTSTART;VALUE=DATE:20261130
DTEND;VALUE=DATE:20261201
SUMMARY:AGuIX: Phase 1/2 readout est. (NCT04881032)
DESCRIPTION:AGuIX\, phase 1/2.\nStudy: AGuIX Nanoparticles With Radiotherap
 y Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Gliobl
 astoma\nEstimated primary completion: November 2026. This is a ClinicalTri
 als.gov estimate\, not a confirmed readout date\, and it can move.\nDrug p
 age: https://assetmemo.bio/drug/aguix#upcoming-events\nRegistry record: ht
 tps://clinicaltrials.gov/study/NCT04881032
URL:https://assetmemo.bio/drug/aguix#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT04899908-2333@assetmemo.bio
DTSTAMP:20261121T005618Z
DTSTART;VALUE=DATE:20280430
DTEND;VALUE=DATE:20280501
SUMMARY:AGuIX: Phase 2 readout est. (NCT04899908)
DESCRIPTION:AGuIX\, phase 2.\nStudy: Stereotactic Brain-directed Radiation 
 With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases\n
 Estimated primary completion: April 2028. This is a ClinicalTrials.gov est
 imate\, not a confirmed readout date\, and it can move.\nDrug page: https:
 //assetmemo.bio/drug/aguix#upcoming-events\nRegistry record: https://clini
 caltrials.gov/study/NCT04899908
URL:https://assetmemo.bio/drug/aguix#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT04789486-2333@assetmemo.bio
DTSTAMP:20261121T005618Z
DTSTART;VALUE=DATE:20280410
DTEND;VALUE=DATE:20280411
SUMMARY:AGuIX: Phase 1/2 readout est. (NCT04789486)
DESCRIPTION:AGuIX\, phase 1/2\, Non-Small Cell Lung Cancer.\nStudy: Nano-SM
 ART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors an
 d Pancreatic Cancer\nEstimated primary completion: 10 April 2028. This is 
 a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can 
 move.\nDrug page: https://assetmemo.bio/drug/aguix#upcoming-events\nRegist
 ry record: https://clinicaltrials.gov/study/NCT04789486
URL:https://assetmemo.bio/drug/aguix#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
